Ken Ohmine

Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria

Junichi Kamiie, Sumio Ohtsuki, Ryo Iwase et al. · Pharmaceutical Research · 2008 · 476 citations

Membrane Transporter, Proteinlipid Interaction, Biochemistry +12

Identification of myelodysplastic syndrome–specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction

Akira Miyazato, Shuichi Ueno, Ken Ohmine et al. · Blood · 2001 · 180 citations · Full text

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

Lymphoid Neoplasia, End-of-induction Pet Response, Medicine +7

Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line

Takahisa Tarumoto, Tadashi Nagai, Ken Ohmine et al. · Experimental Hematology · 2004 · 92 citations

Ascorbic Acid, Chromatin, Reductive Stress +10

A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma

Yasuhito Terui, Shinya Rai, Koji Izutsu et al. · Cancer Science · 2021 · 51 citations · Full text